Amarin Corp Plc (AMRN)

[Biobillionair]

Here's a 50% reference estimate for REDUCE-IT:

"Consistent with prior comments, Amarin estimates that the study will require approximately 8,000 patients and take approximately 6 years for completion. The Company anticipates that if, as intended, it commences Outcomes study activities in 2011 that it will be positioned to achieve approximately 50% enrollment before the end of 2012."

http://www.streetinsider.com/Corporate+News/Amarin+%28AMRN%29+Reaches+Agreement+for+REDUCE-IT+Trial/6702234.html